Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial.
about
Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitusPramlintide for diabetes mellitusAntihypertensive agents for preventing diabetic kidney diseaseTargeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitusTargeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitusPramlintide for diabetes mellitusNephroprotection by Hypoglycemic Agents: Do We Have Supporting Data?Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statementNew insights from monogenic diabetes for "common" type 2 diabetesDoes insulin resistance drive the association between hyperglycemia and cardiovascular risk?Surgical treatment of type 2 diabetes: the surgeon perspective.Challenges associated with insulin therapy progression among patients with type 2 diabetes: Latin American MOSAIc study baseline dataPharmacoeconomic evaluation of diabetic nephropathic patients attending nephrology department in a tertiary care hospital.Challenges in achieving optimal glycemic control in type 2 diabetes patients with declining renal function: The Southeast Asia perspectiveLow-protein diet for the prevention of renal failure.Oral Hypoglycemic Drugs: Pathophysiological Basis of Their Mechanism of ActionOral Hypoglycemic Drugs: Pathophysiological Basis of Their Mechanism of Action.Combined poor diabetes control indicators are associated with higher risks of diabetic retinopathy and macular edema than poor glycemic control aloneNon-invited review: prevention of microvascular diabetic complications by fenofibrate: lessons from FIELD and ACCORD.Cost of treating diabetic kidney disease.Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trialsBlood pressure and pulse pressure effects on renal outcomes in the Veterans Affairs Diabetes Trial (VADT)External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetesNear-Normalization of Glucose and Microvascular Diabetes Complications: Data from ACCORD and ADVANCE.Left ventricular structure and function in prediabetic adults: Relationship with insulin resistance.Blood glucose control and quality of health care in non-insulin-treated patients with Type 2 diabetes in Spain: a retrospective and cross-sectional observational studyTreatment-dependent and treatment-independent risk factors associated with the risk of diabetes-related events: a retrospective analysis based on 229,042 patients with type 2 diabetes mellitus.Observation on renal outcomes in the Veterans Affairs Diabetes TrialComplementary mechanisms of action and rationale for the fixed combination of perindopril and indapamide in treating hypertension - update on clinical utilityCost-effectiveness of implementing the chronic care model for diabetes care in a military population.Medical care costs associated with progression of diabetic nephropathy.Comprehensive Care for People With Diabetic Kidney DiseaseCombined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients.Current therapeutic agents and anesthetic considerations for diabetes mellitusPrevalence of chronic kidney disease and risk factors for its progression: A cross-sectional comparison of Indians living in Indian versus U.S. citiesPrimary prevention of macroangiopathy in patients with short-duration type 2 diabetes by intensified multifactorial intervention: seven-year follow-up of diabetes complications in ChineseIndependent contribution of A1C, systolic blood pressure, and LDL cholesterol control to risk of cardiovascular disease hospitalizations in type 2 diabetes: an observational cohort study.Diabetes, hypertension, and outcome studies: overview 2010.Should A1C targets be individualized for all people with diabetes? Arguments for and against.Effects of intensive control of blood glucose and blood pressure on microvascular complications in patients with type II diabetes mellitus.The influence of baseline risk on the relation between HbA1c and risk for new cardiovascular events and mortality in patients with type 2 diabetes and symptomatic cardiovascular disease.
P2860
Q24186667-43C7F0DF-D1D7-41A5-BEA2-96E2DA53CFA0Q24186857-7574FD6A-12A1-48CB-B8C3-07BB8DD08B02Q24202090-6824EE3F-7FFD-4E1A-A77E-9DB551A0136BQ24202505-0AF75EDB-254E-4ED3-8A1D-51F15D2E847CQ24236456-451A04BA-DA86-4E34-9C5C-2BF75F28C8EEQ24240172-8808C7A3-F2A6-43D8-A107-6948B3B6CAEFQ26777994-513B85DB-CEFF-41BA-B28A-B56BFA285D1BQ26783199-8E25FF2F-626C-42A5-BC54-B441908B5D91Q26795455-B73BEFD9-6381-464C-B3ED-7E08A4AD66E4Q28728387-0731E1A1-DEBB-4D6D-8BE1-0573EC763604Q30405974-17DCD344-205E-49D2-ABA1-167BF6DD7002Q31117218-3FEF668F-7C61-49ED-B410-22B238608C07Q33573338-6EB05B6C-BD6A-4CA7-A238-3CBA9BBBD491Q33587783-BA5397ED-4D87-4675-894F-8D0E6C9C4C7CQ33607693-250B1B79-1289-4E36-8A3F-1ACA8BCEBD95Q33664745-2C6C9855-CBCE-44B9-87AA-C229E3C85F83Q33853527-05D9F7F0-C6F1-45E1-9168-4C0D3831B8CAQ33901914-A0B68E7D-92DA-45FB-95CD-27FFA03241B0Q34024296-7A8F6343-2F88-450D-A132-5A342C043F00Q34083400-0777609C-D9E0-48A8-9EE6-DE620B1EA3CBQ34219430-C9122F54-E31C-4F1B-B1F7-3AFE72886C7FQ34472600-56F89E49-F4BB-4264-AE0A-3D1DF5B112FBQ34475442-945A1188-99B3-4FBD-BC5B-EAF876A8996DQ35060414-0FEBF802-C97C-41F4-8DD9-54D453FFAB93Q35069696-882786AA-20B6-4CD9-A963-89C3BDA4A2F6Q35128612-DBB95B67-12D2-4D82-A0BF-CBACA0CA7DC6Q35179862-5464234E-05E1-4B1B-918D-F0581983CE9DQ35210527-DC1360AB-2AFE-46A1-BAAC-22EFA802B0DDQ35337324-D8401DD8-5BD0-4115-98CD-359E63C56856Q35408341-21A93AC9-435A-4B3B-9834-34A9A1DDB47CQ35953885-BD563154-1CC0-4717-A624-1BCDC7F89372Q36270259-961D1F11-72A6-4362-821B-CC14CFEF6849Q36285262-D0E16C04-A8D2-46B6-87DF-8B4DFCD34B02Q36309045-9B386095-8FDC-41B8-8A95-BABBD619D318Q36720359-8546E6D2-A670-4A46-BD21-39C8FC03E2F3Q36780304-08764BE4-606C-4D43-8393-CFC52D225ED7Q36783690-E9F93768-8ED3-4480-B722-3275122E7575Q36783760-E13F9917-96B9-43FE-AB65-713F4654074EQ36788509-ACC311CC-1D9E-4A42-A4E9-9E840EC5F20CQ37107872-2E5904ED-E99E-4C78-9C9E-378AC8B0B60E
P2860
Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Combined effects of routine bl ...... esults from the ADVANCE trial.
@en
Combined effects of routine bl ...... esults from the ADVANCE trial.
@nl
type
label
Combined effects of routine bl ...... esults from the ADVANCE trial.
@en
Combined effects of routine bl ...... esults from the ADVANCE trial.
@nl
prefLabel
Combined effects of routine bl ...... esults from the ADVANCE trial.
@en
Combined effects of routine bl ...... esults from the ADVANCE trial.
@nl
P2093
P2860
P50
P921
P356
P1433
P1476
Combined effects of routine bl ...... esults from the ADVANCE trial.
@en
P2093
ADVANCE Collaborative Group
Anushka Patel
Avinesh Pillai
Bastiaan E de Galan
Bruce Neal
Diederick Grobbee
Florence Travert
Guiseppe Mancia
Liu Lisheng
Mark Woodward
P2860
P304
P356
10.2337/DC09-0959
P407
P577
2009-08-03T00:00:00Z